Literature DB >> 15996722

Genetic polymorphisms of FAS and FASL (CD95/CD95L) genes in cervical carcinogenesis: An analysis of haplotype and gene-gene interaction.

Hung-Cheng Lai1, Wei-Yu Lin, Ya-Wen Lin, Cheng-Chang Chang, Mu-Hsien Yu, Chia-Chi Chen, Tang-Yuan Chu.   

Abstract

OBJECTIVE: Whereas human papillomavirus (HPV) infection is necessary but not sufficient for cervical carcinogenesis, host genetic variations may confer individual susceptibility. Resistance to apoptosis is a hallmark of cancer in which FAS/FAS ligand signaling plays an important role. The present study examines the hypothesis that genetic polymorphisms in FAS and FAS ligand genes, alone or in combination, are associated with cervical carcinogenesis.
METHODS: The genotypes of FAS -670A/G, FAS -1377G/A, and FASL -844C/T were assessed in 143 patients with high-grade squamous intraepithelial lesions (HSIL), 175 patients with invasive squamous cell carcinomas (SCC), and in age-matched controls by real-time PCR with allele-specific TaqMan probes. The status of cervical high-risk HPV infection was determined and adjusted to test the independence of genotype in the risk assessment.
RESULTS: The A-allele and AA-genotype frequencies of FASA -670G were significantly higher in HSIL/SCC than in controls (60% vs. 54%, P = 0.04, OR 1.26 [95% CI 1.01-1.57]; 38.0% vs. 28.6%, P = 0.02, OR 1.70 [95% CI 1.07-2.70]). No association between FAS -1377 or FASL -844 polymorphisms and HSIL/SCC could be identified. The FAS -1377A/-670A haplotype conferred a higher risk for HSIL/SCC (OR 3.05, 95% CI 1.28-7.30) than FAS -670A alone (OR 1.26, 95% CI 1.28-7.30). The interaction between FAS -670AA and FASL -844CC genotypes was associated with a risk of HSIL/SCC (OR 2.13, 95% CI 1.06-4.29) higher than that of the FAS -670AA genotype alone (OR 1.70, 95% CI 1.07-2.70).
CONCLUSIONS: The FAS -1377A/-670A haplotype in combination with FASL -844C is associated with cervical carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15996722     DOI: 10.1016/j.ygyno.2005.05.010

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  36 in total

1.  FAS and FASLG genetic variants and risk for second primary malignancy in patients with squamous cell carcinoma of the head and neck.

Authors:  Dapeng Lei; Erich M Sturgis; Li-E Wang; Zhensheng Liu; Mark E Zafereo; Qingyi Wei; Guojun Li
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-05-25       Impact factor: 4.254

2.  FAS -1,377 G/A polymorphism is associated with cancer susceptibility: evidence from 10,564 cases and 12,075 controls.

Authors:  Li-Xin Qiu; Jian Shi; Hui Yuan; Xin Jiang; Kai Xue; Hai-Feng Pan; Jin Li; Ming-Hua Zheng
Journal:  Hum Genet       Date:  2009-02-19       Impact factor: 4.132

3.  Genetic association between CD95 rs2234767 polymorphism and cervical cancer risk: a meta analysis.

Authors:  Ping Liu; Zibai Wei; Xiaofeng He; Junyan Yu; Xiangyang Tian; Jianlan Chang
Journal:  Int J Clin Exp Med       Date:  2015-02-15

4.  Apoptotic variants as predictors of risk of oropharyngeal cancer recurrence after definitive radiotherapy.

Authors:  Fenghua Zhang; Erich M Sturgis; Yan Sun; Yang Zhang; Qingyi Wei; Caiyun Zhang; Hongliang Zheng; Guojun Li
Journal:  Int J Cancer       Date:  2015-07-27       Impact factor: 7.396

5.  Genetic variations in T-cell activation and effector pathways modulate alloimmune responses after allogeneic hematopoietic stem cell transplantation in patients with hematologic malignancies.

Authors:  Haowen Xiao; Yi Luo; Xiaoyu Lai; Shan Fu; Jimin Shi; Yamin Tan; Jingsong He; Wanzhuo Xie; Weiyan Zheng; Li-Mengmeng Wang; Lifei Zhang; Lizhen Liu; Xiujin Ye; Xiaohong Yu; Zhen Cai; Maofang Lin; He Huang
Journal:  Haematologica       Date:  2012-06-24       Impact factor: 9.941

6.  Significant association among the Fas -670 A/G (rs1800682) polymorphism and esophageal cancer, hepatocellular carcinoma, and prostate cancer susceptibility: a meta-analysis.

Authors:  Tao Liu; Li Zuo; Lin Li; Lei Yin; Kai Liang; Hongyuan Yu; Hui Ren; Wen Zhou; Hongwei Jing; Yang Liu; Chuize Kong
Journal:  Tumour Biol       Date:  2014-08-02

7.  Letter regarding Wang GQ et al. entitled "associations between Fas/FasL polymorphisms and susceptibility to cervical cancer: a meta-analysis".

Authors:  Ying Zeng; Jia Liu; Jinjin Yan; Hui Liu; Shuhua Xiong
Journal:  Tumour Biol       Date:  2014-07-04

8.  Association between CD95L polymorphism and cervical cancer risk: evidence from a meta-analysis.

Authors:  Jing Zhu; Lei Lu; Xiang Cheng; Rongkai Xie; Zhengqiong Chen; Youfei Li; Guilan Lin; Jianmei Liu; Ying Yang
Journal:  Tumour Biol       Date:  2014-03-12

9.  Lack of association between the FAS/FASL polymorphisms and cervical cancer risk: A meta-analysis.

Authors:  Yingying DU; Lixia Hu; Yueyin Pan
Journal:  Biomed Rep       Date:  2013-01-17

10.  Fas and FasL gene polymorphisms are not associated with cervical cancer but differ among Black and Mixed-ancestry South Africans.

Authors:  Koushik Chatterjee; Malin Engelmark; Ulf Gyllensten; Collet Dandara; Lize van der Merwe; Ushma Galal; Margaret Hoffman; Anna-Lise Williamson
Journal:  BMC Res Notes       Date:  2009-11-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.